Physician profile
Michael Palese
NPI 1679576110
$55,459.60
in general payments reported to CMS, 2019-2025
38 companies · $9,938 in 2025
The $9,938 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,848 · 2020: $4,890 · 2021: $5,673 · 2022: $8,739 · 2023: $13K · 2024: $4,276 · 2025: $9,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $7,526 · Consulting Fee: $3,295 · Travel and Lodging: $2,654 · Honoraria: $1,249 · Education: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,200.00 |
| Food and Beverage | $7,526.34 |
| Consulting Fee | $3,295.10 |
| Travel and Lodging | $2,653.78 |
| Honoraria | $1,249.00 |
| Education | $384.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27,641.53 | 2019-2025 | Spaceoar System, Rezum Generator, Spaceoar Vue System - 10ml |
| Intuitive Surgical, INC. | $9,020.41 | 2019-2024 | |
| Ambu INC. | $5,278.26 | 2020-2025 | |
| Calyxo, INC. | $3,470.51 | 2024-2025 | Cvac Aspiration System |
| Ambu A/S | $3,269.10 | 2023-2024 | |
| Astellas Pharma US INC | $832.92 | 2019-2025 | Xtandi, Myrbetriq |
| Urogen Pharma, INC. | $792.69 | 2021-2025 | |
| Palette Life Sciences, INC. | $772.92 | 2021-2023 | |
| Pfizer INC. | $517.60 | 2019-2025 | |
| Procept Biorobotics Corporation | $436.88 | 2022-2023 | Aquabeam Robotic System |
| Edap Technomed INC | $424.90 | 2022-2025 | |
| Teleflex LLC | $362.91 | 2021-2025 | Urolift |
| Profound Medical Corp. | $338.19 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $254.06 | 2025 | Adstiladrin |
| Koelis INC. | $179.62 | 2022-2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $158.87 | 2022-2025 | Pylarify |
| Hollister Incorporated | $148.37 | 2022-2023 | Vapro, Infyna Chic, Vapro Pocket |
| Janssen Scientific Affairs, LLC | $137.35 | 2019-2020 | |
| Blue Earth Diagnostics | $129.00 | 2023-2024 | |
| Ethicon US, LLC | $116.39 | 2024 | Neuwave |
| Bard Access Systems, INC. | $108.19 | 2019 | |
| Sumitomo Pharma America, INC. | $105.81 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $102.26 | 2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $96.31 | 2025 | Provenge |
| Becton, Dickinson and Company | $90.82 | 2025 | Bd Onclarity |
| Abbvie INC. | $85.00 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.35 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $72.16 | 2024-2025 | Keytruda |
| Coloplast Corp | $69.31 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $62.62 | 2024 | Trelstar |
| Novartis Pharmaceuticals Corporation | $56.22 | 2025 | |
| Medtronic, INC. | $50.04 | 2025 | Interstim, V-Loc 180 |
| Davol INC. | $48.96 | 2020 | |
| Olympus America INC. | $47.55 | 2020-2025 | Itind System |
| Sagent Pharmaceuticals | $34.35 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $23.47 | 2022 | |
| 180 Medical, INC. | $21.15 | 2019 | |
| Tolmar, INC. | $18.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Palese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.